Analytical methods to assess nanoparticle toxicity
… Sara Love is currently a Ph.D. candidate in Chemistry at the University of Minnesota under …
is uncharged at physiological pH and is able to enter both live and dead cells. In live cells it is …
is uncharged at physiological pH and is able to enter both live and dead cells. In live cells it is …
Assessing nanoparticle toxicity
SA Love, MA Maurer-Jones… - Annual review of …, 2012 - annualreviews.org
… is also critical for the interpretation of results. The determination of a dosing metric is inherently
complicated because little is … Accordingly, there is little consistency in dosing metrics …
complicated because little is … Accordingly, there is little consistency in dosing metrics …
Correlation of Alzheimer disease neuropathologic changes with cognitive status: a review of the literature
… In early stages (I–III), the pathologic finding is mostly isolated to … Hippocampal pathology is
ubiquitous in AD patients but is … Hippocampal pathology is ubiquitous in AD patients but is not …
ubiquitous in AD patients but is … Hippocampal pathology is ubiquitous in AD patients but is not …
Meta-analysis of 74,046 individuals identifies 11 new susceptibility loci for Alzheimer's disease
Eleven susceptibility loci for late-onset Alzheimer's disease (LOAD) were identified by previous
studies; however, a large portion of the genetic risk for this disease remains unexplained. …
studies; however, a large portion of the genetic risk for this disease remains unexplained. …
[HTML][HTML] A DNA methylation biomarker of alcohol consumption
The lack of reliable measures of alcohol intake is a major obstacle to the diagnosis and
treatment of alcohol-related diseases. Epigenetic modifications such as DNA methylation may …
treatment of alcohol-related diseases. Epigenetic modifications such as DNA methylation may …
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
We undertook a two-stage genome-wide association study (GWAS) of Alzheimer's disease (AD)
involving over 16,000 individuals, the most powerful AD GWAS to date. In stage 1 (3,941 …
involving over 16,000 individuals, the most powerful AD GWAS to date. In stage 1 (3,941 …
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
…, S Schreiber, M Mayhaus, S Nicolhaus, S Wagenpfeil… - Nature …, 2011 - nature.com
We sought to identify new susceptibility loci for Alzheimer's disease through a staged
association study (GERAD+) and by testing suggestive loci reported by the Alzheimer's Disease …
association study (GERAD+) and by testing suggestive loci reported by the Alzheimer's Disease …
[HTML][HTML] Spread of SARS-CoV-2 in the Icelandic population
… It is unclear whether this is because females and children are less likely to be infected by
SARS-CoV-2 or because Covid-19 is less likely to become symptomatic after infection in these …
SARS-CoV-2 or because Covid-19 is less likely to become symptomatic after infection in these …
[HTML][HTML] Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial
…, V Hopkins, A Bayer, RW Jones, R Bullock, S Love… - The Lancet, 2008 - thelancet.com
… The results of this study suggest that plaque removal is not enough to halt progressive
neurodegeneration in Alzheimer's disease and prompt some intriguing challenges to the amyloid …
neurodegeneration in Alzheimer's disease and prompt some intriguing challenges to the amyloid …
Influence of delay on survival in patients with breast cancer: a systematic review
MA Richards, AM Westcombe, SB Love, P Littlejohns… - The Lancet, 1999 - thelancet.com
… The impact on survival of delays between the onset of symptoms and the start of treatment
is controversial and cannot be studied in randomised controlled trials. We did a systematic …
is controversial and cannot be studied in randomised controlled trials. We did a systematic …